- Report
- November 2019
- 41 Pages
Germany
- Report
- July 2022
- 150 Pages
Global
From €2027EUR$2,250USD£1,788GBP
- Report
- December 2020
- 64 Pages
United States
From €766EUR$850USD£676GBP
- Report
- May 2024
- 167 Pages
Global
From €2252EUR$2,500USD£1,987GBP
- Report
- August 2020
- 139 Pages
Global
From €2477EUR$2,750USD£2,186GBP
- Report
- March 2024
- 150 Pages
Global
From €5360EUR$5,950USD£4,729GBP
- Report
- January 2024
- 150 Pages
Global
From €5360EUR$5,950USD£4,729GBP
- Report
- November 2020
- 82 Pages
North America
From €5360EUR$5,950USD£4,729GBP
- Report
- November 2024
- 120 Pages
Latin America
From €5360EUR$5,950USD£4,729GBP
- Report
- December 2021
- 200 Pages
Global
From €2162EUR$2,400USD£1,908GBP
- Report
- May 2024
- 256 Pages
Global
From €3603EUR$4,000USD£3,179GBP
- Report
- August 2022
- 115 Pages
Global
From €4054EUR$4,500USD£3,577GBP
- Report
- January 2024
- 395 Pages
Global
From €5405EUR$6,000USD£4,769GBP
€6756EUR$7,500USD£5,961GBP
- Report
- August 2024
- 233 Pages
Global
From €5729EUR$6,360USD£5,055GBP
€7161EUR$7,950USD£6,319GBP
- Report
- June 2024
- 200 Pages
Global
From €5729EUR$6,360USD£5,055GBP
€7161EUR$7,950USD£6,319GBP
- Report
- June 2024
- 260 Pages
Global
From €5729EUR$6,360USD£5,055GBP
€7161EUR$7,950USD£6,319GBP
- Report
- June 2023
- 159 Pages
Global
From €5405EUR$6,000USD£4,769GBP
€6756EUR$7,500USD£5,961GBP
- Report
- February 2023
- 198 Pages
Global
From €5405EUR$6,000USD£4,769GBP
€6756EUR$7,500USD£5,961GBP
- Report
- February 2024
- 110 Pages
Global
From €4279EUR$4,750USD£3,775GBP
- Report
- February 2024
- 114 Pages
Global
From €4279EUR$4,750USD£3,775GBP

Cannabidiol (CBD) is a cannabinoid found in the Cannabis sativa plant. It is a non-psychoactive compound that has been studied for its potential therapeutic effects on the central nervous system (CNS). CBD has been found to have anti-inflammatory, antioxidant, and neuroprotective properties, and has been studied for its potential to treat a variety of neurological disorders, including epilepsy, anxiety, depression, and Parkinson's disease.
CBD is increasingly being used as an alternative to traditional CNS drugs, such as benzodiazepines and opioids. It is being studied for its potential to reduce the side effects of traditional medications, as well as its potential to treat a variety of neurological conditions.
The CBD market is growing rapidly, with a variety of products available, including oils, tinctures, edibles, and topical creams. Companies in the market include Charlotte's Web, Elixinol, and Endoca. Show Less Read more